2026-05-27 2026-05-27 , online online, 1,690 € plus tax Dr. Willi Schnorpfeil https://www.forum-institut.com/seminar/26102002-market-access-healthcare-management-fundamentals/referenten/26/26_10/26102002-market-access-healthcare-management-fundamentals_schnorpfeil-willi.jpg Market Access & Healthcare Management Fundamentals

Market Access of innovative medicines in Europe - here you will learn the key concepts from strategy to roll-out.

Topics
  • Structuring the European landscape: key health financing models and pharmaceutical market archetypes
  • Market Access preparation: defining an integrated evidence package
  • EU HTA and the interplay with national HTA systems
  • (Pre) launch communication & Market Access in Germany


Who should attend
This training course is designed for pharmaceutical industry professionals who need a solid foundation in market access - including new market access specialists and managers as well as marketing, medical and clinical affairs teams looking to support market access activities more effectively.
Aims and objectives
Gain a solid foundation in market access at EU and national level - focused on innovative medicines.

Four industry experts will guide you through the European payer landscape: financial models, payer archetypes, and HTA implications. Germany's HTA system serves as a deep-dive example of a value-based market.

Leave with strategic and operational know-how to drive your next launch from a market access perspective
Your benefit

  • Four industry experts with outstanding know-how in HTA, pricing, reimbursement and launch preparation guide you through the market access process
  • Learn the crucial points for successful market access and avoid common pitfalls
  • Practical case study to apply your knowledge

26102002 Seminar Market Access & Healthcare Management Fundamentals

Market Access & Healthcare Management Fundamentals

Benefits
  • Experts with outstanding know-how in HTA, pricing, reimbursement and launch preparation
  • Learn the crucial points for successful market access
  • Practical case study to apply your knowledge

Webcode 26102002

Book now

JETZT Buchen
Speakers

Dr. Willi Schnorpfeil

WS Value & Dossier GmbH

Owner
More information please click here.

Victoria Unmüßig

Astellas Pharma GmbH

EU HTA Lead; Global Access & Value and Public Policy
More information please click here.

Anne Martin

J&J Innovative Medicine

Director Contracting, Price & Analytics Hub

Mona Glogger

AccessMatters GmbH

managing partner of AccessMatters GmbH, a specialized consulting company in the areas of pharmaceutical market access, reimbursement, HTA, and pricing in Germany-all embedded within European and global commercial business strategy. Mona held held various leadership industry positions at different companies such as Bristol Myers Squibb, Celgene, AbbVie - from market access to HTA and pricing. With more than 10 years of industry experience, Mona has successfully supported product launches in cross-functional matrix teams from a business perspective and advocates for a broad understanding of market access in order to successfully and sustainably navigate complex market access environments.
More information please click here.

Everything at a glance

Appointment

20 - 21/10/2026

20 - 21/10/2026

Period

Tag 1: 9.00 - 17.00 Uhr
Tag 2: 9.00 - 13.30 Uhr

Tag 1: 9.00 - 17.00 Uhr
Tag 2: 9.00 - 13.30 Uhr
Venue

online

online

Downloads
Market Access Basics
Market Access Basics
Fee

Event - 1,690€ plus tax
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.

Event - 1,690€ plus tax
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.

Inhouse-offers
Request inhouse-offer
Request inhouse-offer

Book now

Your contact

Dr. Henriette Wolf-Klein
Head of Department

+49 6221 500-680
h.wolf-klein@forum-institut.de

Details

Market Access of innovative medicines in Europe - here you will learn the key concepts from strategy to roll-out.

Topics

  • Structuring the European landscape: key health financing models and pharmaceutical market archetypes
  • Market Access preparation: defining an integrated evidence package
  • EU HTA and the interplay with national HTA systems
  • (Pre) launch communication & Market Access in Germany


Who should attend
This training course is designed for pharmaceutical industry professionals who need a solid foundation in market access - including new market access specialists and managers as well as marketing, medical and clinical affairs teams looking to support market access activities more effectively.

Aims and objectives

Gain a solid foundation in market access at EU and national level - focused on innovative medicines.

Four industry experts will guide you through the European payer landscape: financial models, payer archetypes, and HTA implications. Germany's HTA system serves as a deep-dive example of a value-based market.

Leave with strategic and operational know-how to drive your next launch from a market access perspective

Your benefit

  • Four industry experts with outstanding know-how in HTA, pricing, reimbursement and launch preparation guide you through the market access process
  • Learn the crucial points for successful market access and avoid common pitfalls
  • Practical case study to apply your knowledge

Detailed programme

Tag 1: 9.00 - 17.00 Uhr
Tag 2: 9.00 - 13.30 Uhr

Welcome and introduction


Anne Martin

Healthcare systems and the consequences for pricing & reimbursement in Europe
  • History of healthcare systems (i.e. Bismarck, Beveridge); stakeholders, financing, developments and trends
  • Structuring the European landscape: key health financing models and pharmaceutical market archetypes (cost effectiveness, comparative-effectiveness, budget-impact and hybrid systems)
  • How system logics translate into pricing and reimbursement pathways
  • (Country) specific examples of pricing and reimbursement, including price negotiations, value based pricing, contracting models (e.g. pay for performance), managed entry examples
  • International perspective: reference pricing, launching
  • Market implications: how financing models translate into pricing, reimbursement, and access decision making
[2 coffee breaks included in the morning session]

Lunch break


Dr Willi Schnorpfeil

Market Access preparation: defining an integrated evidence package
  • Clinical evidence (RCT) and Patient relevant evidence (PROs, RWE)
  • Marketing authorisation - labelling, product information
  • HEOR aspects as QALYs, only applicable in cost driven markets?

Coffee break


Victoria Unmüßig

EU HTA and the interplay with national HTA systems
  • EU HTA framework and process: scope of Joint Clinical Assessments, roles of EU and national bodies, and interaction with national HTA
  • Timelines and methodology: key procedural steps, assessment timelines, clinical domains, and methodological requirements
  • Implications for market access strategy: evidence planning, national adaptation, and remaining areas of national decision making beyond EU HTA
  • From volume to value: to what extent does EU HTA accelerate or reshape access decision making across Europe?

End of day one


Mona Glogger

Creating the Access Environment - example Germany
  • Relevant stakeholders & stakeholder management

Coffee break


Dr Willi Schnorpfeil

(Pre) launch communication
  • European level: European advisory boards, publications
  • National level - example Germany: National KOLs
  • Conflict of interests

Short break


Mona Glogger

Case Study: Project management
  • European access
  • National access
  • Regional access

End of day 2


Good to know

Technical requirements

You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.

We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.

This distinguishes our events

of 5 stars of all ratings from 2025

of 5 stars on Trustpilot = good

Recommendations

EU Requirements for Labelling, UDI & Product Information

Compact overview of EU requirements for labelling, UDI and product information under the MDR. Learn how legal obligation...

08.07.2026 in
Details

Most Favored Nation (MFN) Principle - Focus Pharma

Understand how the Most Favored Nation (MFN) principle is reshaping global pharmaceutical business. This compact online ...

17.06.2026 in
Details

Leveraging AI in Evidence Generation and Market Access

Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essent...

14.10.2026 in
Details

Disease Awareness Campaigns

Enable teams to plan and run unbranded, non-promotional disease awareness campaigns that inform the public responsibly, ...

09.07.2026 in
Details

ExpertFORUM Global Regulatory Affairs

This online conference offers compact expert talks and diverse perspectives on global regulatory strategies, digital tra...

17. - 18.09.2026 in
Details

Go forward

In-house seminars

Our programmes are also available for in-house training. Just contact us!

Details
In-house seminars
List of abbreviations pharma & healthcare

Many abbreviations are used in pharma & healthcare. Download the list of the most important ones.

Details
Abbreviations, Glossary
We guarantee the highest quality

We are now officially certified to ISO 9001 and ISO 21001 standard.

Details
We guarantee the highest quality